173 related articles for article (PubMed ID: 12575848)
1. Low frequency of beta-catenin gene mutations in pilomatricoma.
Ha SJ; Kim JS; Seo EJ; Lee KH; Lee HJ; Kim JW
Acta Derm Venereol; 2002; 82(6):428-31. PubMed ID: 12575848
[TBL] [Abstract][Full Text] [Related]
2. beta-catenin expression in pilomatrixomas. Relationship with beta-catenin gene mutations and comparison with beta-catenin expression in normal hair follicles.
Moreno-Bueno G; Gamallo C; Pérez-Gallego L; Contreras F; Palacios J
Br J Dermatol; 2001 Oct; 145(4):576-81. PubMed ID: 11703283
[TBL] [Abstract][Full Text] [Related]
3. A common human skin tumour is caused by activating mutations in beta-catenin.
Chan EF; Gat U; McNiff JM; Fuchs E
Nat Genet; 1999 Apr; 21(4):410-3. PubMed ID: 10192393
[TBL] [Abstract][Full Text] [Related]
4. beta-Catenin gene mutation in human hair follicle-related tumors.
Kajino Y; Yamaguchi A; Hashimoto N; Matsuura A; Sato N; Kikuchi K
Pathol Int; 2001 Jul; 51(7):543-8. PubMed ID: 11472567
[TBL] [Abstract][Full Text] [Related]
5. beta-Catenin mutation and its nuclear localization are confirmed to be frequent causes of Wnt signaling pathway activation in pilomatricomas.
Xia J; Urabe K; Moroi Y; Koga T; Duan H; Li Y; Furue M
J Dermatol Sci; 2006 Jan; 41(1):67-75. PubMed ID: 16378715
[TBL] [Abstract][Full Text] [Related]
6. Pilomatrix carcinomas contain mutations in CTNNB1, the gene encoding beta-catenin.
Lazar AJ; Calonje E; Grayson W; Dei Tos AP; Mihm MC; Redston M; McKee PH
J Cutan Pathol; 2005 Feb; 32(2):148-57. PubMed ID: 15606674
[TBL] [Abstract][Full Text] [Related]
7. Pilomatricomas contain activating mutations in beta-catenin.
Chan EF
J Am Acad Dermatol; 2000 Oct; 43(4):701-2. PubMed ID: 11004631
[No Abstract] [Full Text] [Related]
8. [Beta-catenin mutations in a common skin cancer: pilomatricoma].
Durand M; Molès JP
Bull Cancer; 1999 Sep; 86(9):725-6. PubMed ID: 10519964
[TBL] [Abstract][Full Text] [Related]
9. beta-Catenin expression in the transitional cell zone of pilomatricoma.
Park SW; Suh KS; Wang HY; Kim ST; Sung HS
Br J Dermatol; 2001 Oct; 145(4):624-9. PubMed ID: 11703290
[TBL] [Abstract][Full Text] [Related]
10. Mutations in beta-catenin and APC genes are uncommon in esophageal and esophagogastric junction adenocarcinomas.
Choi YW; Heath EI; Heitmiller R; Forastiere AA; Wu TT
Mod Pathol; 2000 Oct; 13(10):1055-9. PubMed ID: 11048797
[TBL] [Abstract][Full Text] [Related]
11. Microsatellite analysis of the adenomatous polyposis coli (APC) gene and immunoexpression of beta catenin in nephroblastoma: a study including 83 cases treated with preoperative chemotherapy.
Ramburan A; Oladiran F; Smith C; Hadley GP; Govender D
J Clin Pathol; 2005 Jan; 58(1):44-50. PubMed ID: 15623481
[TBL] [Abstract][Full Text] [Related]
12. [Principal features of multiple pilomatricoma and its association with beta-catenin mutation].
Faviou E; Baltogiannis N; Cigliano B; D'Agostino S
An Pediatr (Barc); 2005 Jun; 62(6):593-4; author reply 594. PubMed ID: 15927129
[No Abstract] [Full Text] [Related]
13. Fibromatosis of the breast and mutations involving the APC/beta-catenin pathway.
Abraham SC; Reynolds C; Lee JH; Montgomery EA; Baisden BL; Krasinskas AM; Wu TT
Hum Pathol; 2002 Jan; 33(1):39-46. PubMed ID: 11823972
[TBL] [Abstract][Full Text] [Related]
14. Abnormalities of the APC/beta-catenin pathway in endometrial cancer.
Moreno-Bueno G; Hardisson D; Sánchez C; Sarrió D; Cassia R; García-Rostán G; Prat J; Guo M; Herman JG; Matías-Guiu X; Esteller M; Palacios J
Oncogene; 2002 Nov; 21(52):7981-90. PubMed ID: 12439748
[TBL] [Abstract][Full Text] [Related]
15. The APC/beta-catenin pathway in ulcerative colitis-related colorectal carcinomas: a mutational analysis.
Aust DE; Terdiman JP; Willenbucher RF; Chang CG; Molinaro-Clark A; Baretton GB; Loehrs U; Waldman FM
Cancer; 2002 Mar; 94(5):1421-7. PubMed ID: 11920497
[TBL] [Abstract][Full Text] [Related]
16. Germline APC mutation on the beta-catenin binding site is associated with a decreased apoptotic level in colorectal adenomas.
Venesio T; Balsamo A; Scordamaglia A; Bertolaso M; Arrigoni A; Sprujevnik T; Rossini FP; Risio M
Mod Pathol; 2003 Jan; 16(1):57-65. PubMed ID: 12527714
[TBL] [Abstract][Full Text] [Related]
17. Loss of membranous expression of beta-catenin is associated with tumor progression in cutaneous melanoma and rarely caused by exon 3 mutations.
Demunter A; Libbrecht L; Degreef H; De Wolf-Peeters C; van den Oord JJ
Mod Pathol; 2002 Apr; 15(4):454-61. PubMed ID: 11950921
[TBL] [Abstract][Full Text] [Related]
18. Analysis of somatic APC mutations in rare extracolonic tumors of patients with familial adenomatous polyposis coli.
Bläker H; Sutter C; Kadmon M; Otto HF; Von Knebel-Doeberitz M; Gebert J; Helmke BM
Genes Chromosomes Cancer; 2004 Oct; 41(2):93-8. PubMed ID: 15287021
[TBL] [Abstract][Full Text] [Related]
19. APC, beta-catenin, and E-cadherin and the development of recurrent endometrial carcinoma.
Pijnenborg JM; Kisters N; van Engeland M; Dunselman GA; de Haan J; de Goeij AF; Groothuis PG
Int J Gynecol Cancer; 2004; 14(5):947-56. PubMed ID: 15361208
[TBL] [Abstract][Full Text] [Related]
20. Cribriform-morular variant of papillary thyroid carcinoma: a pathological and molecular genetic study with evidence of frequent somatic mutations in exon 3 of the beta-catenin gene.
Xu B; Yoshimoto K; Miyauchi A; Kuma S; Mizusawa N; Hirokawa M; Sano T
J Pathol; 2003 Jan; 199(1):58-67. PubMed ID: 12474227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
